|
FOBS
|
5
|
Resverlogix Corp.
|
Jul 27, 2019 11:37PM
|
|
Gilead / Galapagos NV
|
1
|
Resverlogix Corp.
|
Jul 15, 2019 10:45AM
|
|
HDL Functionality
|
2
|
Resverlogix Corp.
|
May 06, 2019 10:31AM
|
|
J&J Abiraterone going generic
|
4
|
Zenith Epigenetics
|
Nov 21, 2018 02:31PM
|
|
Lending Shares
|
4
|
Resverlogix Corp.
|
Jul 29, 2019 11:54AM
|
|
Lockup
|
2
|
Resverlogix Corp.
|
May 17, 2019 09:53AM
|
|
Mace Events Study / Type 2 Diabetes / Control Arms 26 CVOT Trials
|
2
|
Resverlogix Corp.
|
Nov 28, 2018 12:50PM
|
|
Market Pricing
|
6
|
Resverlogix Corp.
|
Jun 12, 2019 04:41PM
|
|
Peter Libby
|
9
|
Resverlogix Corp.
|
Aug 14, 2019 09:31AM
|
|
Peter Libby / You Tube Interview
|
6
|
Resverlogix Corp.
|
Aug 16, 2019 07:59AM
|
|
Potential Market Size
|
2
|
Resverlogix Corp.
|
Apr 18, 2019 11:52AM
|
|
Prostate Ca / Brd4
|
4
|
Zenith Epigenetics
|
Feb 21, 2019 09:49AM
|
|
Publication / Resverlogix An Author
|
3
|
Resverlogix Corp.
|
Aug 20, 2019 10:46AM
|
|
R & D
|
4
|
Resverlogix Corp.
|
Jul 30, 2019 11:12AM
|
|
Re: 3 point MACE in Phase 3 should be 10% percent lower than 4 point MACE in Phase 2's
|
4
|
Resverlogix Corp.
|
Nov 06, 2018 10:50AM
|
|
Re: 3 point MACE in Phase 3 should be 10% percent lower than 4 point MACE in Phase 2's
|
3
|
Resverlogix Corp.
|
Nov 06, 2018 11:26AM
|
|
Re: 3 point MACE vs 5 point MACE
|
2
|
Resverlogix Corp.
|
Nov 02, 2018 06:27PM
|
|
Re: 3 point MACE vs 5 point MACE
|
1
|
Resverlogix Corp.
|
Nov 02, 2018 06:39PM
|
|
Re: 3 point MACE vs 5 point MACE
|
2
|
Resverlogix Corp.
|
Nov 02, 2018 11:06PM
|
|
Re: 3 point MACE vs 5 point MACE
|
5
|
Resverlogix Corp.
|
Nov 03, 2018 04:38AM
|
